Afya Limited Announces Entering Into a Share Purchase Agreement for the Acquisition of Faculdade Única de Contagem
Afya (Nasdaq: AFYA; B3: A2FY34) has entered into a share purchase agreement to acquire 100% of Faculdade Única de Contagem (FUNIC) through its subsidiary Afya Participações S.A. The acquisition adds 60 medical school seats in Contagem, Minas Gerais, marking Afya's fifth medical school in the state. The total purchase price is R$ 100 million, with R$ 60 million paid in cash at closing and R$ 40 million in three annual CDI-adjusted installments.
The deal includes potential for 60 additional seats if approved by MEC within 36 months, with R$ 1 million payment per granted seat. At full maturity in 2030, Afya expects an EV/EBITDA of 3.3x with projected Net Revenues of R$ 52.4 million from Medicine operations.
Afya (Nasdaq: AFYA; B3: A2FY34) ha stipulato un accordo per l'acquisto di azioni per acquisire il 100% della Faculdade Única de Contagem (FUNIC) attraverso la sua controllata Afya Participações S.A. L'acquisizione aggiunge 60 posti di scuola di medicina a Contagem, Minas Gerais, rappresentando la quinta scuola di medicina di Afya nello stato. Il prezzo totale di acquisto è di 100 milioni di R$, con 60 milioni di R$ pagati in contante al momento della chiusura e 40 milioni di R$ in tre rate annuali aggiustate al CDI.
L'accordo prevede la possibilità di 60 posti aggiuntivi se approvati dal MEC entro 36 mesi, con un pagamento di 1 milione di R$ per ogni posto concesso. Al pieno raggiungimento nel 2030, Afya prevede un EV/EBITDA di 3,3x con ricavi netti previsti di 52,4 milioni di R$ dalle operazioni di Medicina.
Afya (Nasdaq: AFYA; B3: A2FY34) ha entrado en un acuerdo de compra de acciones para adquirir el 100% de Faculdade Única de Contagem (FUNIC) a través de su subsidiaria Afya Participações S.A. La adquisición añade 60 plazas en la escuela de medicina en Contagem, Minas Gerais, siendo la quinta escuela de medicina de Afya en el estado. El precio total de compra es de 100 millones de R$, con 60 millones de R$ pagados en efectivo al cierre y 40 millones de R$ en tres cuotas anuales ajustadas por CDI.
El acuerdo incluye la posibilidad de 60 plazas adicionales si son aprobadas por el MEC en un plazo de 36 meses, con un pago de 1 millón de R$ por cada plaza concedida. A plena madurez en 2030, Afya espera un EV/EBITDA de 3,3x con ingresos netos proyectados de 52,4 millones de R$ de las operaciones de Medicina.
Afya (Nasdaq: AFYA; B3: A2FY34)는 자회사 Afya Participações S.A.를 통해 Faculdade Única de Contagem (FUNIC)의 100%를 인수하는 주식 매매 계약을 체결했습니다. 이번 인수는 미나스 제라이스 주의 콘탐겐에서 60개의 의대 자리를 추가하며, Afya의 주 내 다섯 번째 의대가 됩니다. 총 인수가는 1억 레알이며, 6천만 레알이 계약 체결 시 현금으로 지급되고 4천만 레알은 3년 동안 CDI 조정으로 지급됩니다.
이번 거래에는 MEC의 승인을 받을 경우 60개의 추가 자리를 확보할 가능성이 있으며, 승인된 자리마다 100만 레알의 지급이 필요합니다. 2030년 완전 성숙기에는 Afya가 3.3배의 EV/EBITDA를 기대하며, 의학 분야에서 5,240만 레알의 순수익을 예상하고 있습니다.
Afya (Nasdaq: AFYA; B3: A2FY34) a conclu un accord d'achat d'actions pour acquérir 100 % de la Faculdade Única de Contagem (FUNIC) par l'intermédiaire de sa filiale Afya Participações S.A. Cette acquisition ajoute 60 places en école de médecine à Contagem, Minas Gerais, marquant la cinquième école de médecine d'Afya dans l'État. Le prix total d'achat est de 100 millions de R$, avec 60 millions de R$ payés en espèces à la clôture et 40 millions de R$ en trois versements annuels ajustés au CDI.
L'accord comprend la possibilité de 60 places supplémentaires si approuvées par le MEC dans un délai de 36 mois, avec un paiement de 1 million de R$ par place attribuée. À pleine maturité en 2030, Afya s'attend à un EV/EBITDA de 3,3x avec des revenus nets projetés de 52,4 millions de R$ provenant des opérations médicales.
Afya (Nasdaq: AFYA; B3: A2FY34) hat eine Aktienkaufvereinbarung unterzeichnet, um 100% der Faculdade Única de Contagem (FUNIC) über ihre Tochtergesellschaft Afya Participações S.A. zu erwerben. Die Akquisition fügt 60 Studienplätze für Medizinstudenten in Contagem, Minas Gerais, hinzu und stellt Afyas fünfte medizinische Fakultät im Bundesstaat dar. Der Gesamtkaufpreis beträgt 100 Millionen R$, wobei 60 Millionen R$ bei Abschluss in bar gezahlt werden und 40 Millionen R$ in drei jährlichen, an den CDI angepassten Raten gezahlt werden.
Das Geschäft beinhaltet die Möglichkeit für 60 zusätzliche Studienplätze, wenn sie innerhalb von 36 Monaten vom MEC genehmigt werden, mit einer Zahlung von 1 Million R$ pro genehmigten Platz. Bei voller Auslastung im Jahr 2030 erwartet Afya ein EV/EBITDA von 3,3x mit prognostizierten Nettoumsätzen von 52,4 Millionen R$ aus den Medizinbetrieben.
- Acquisition adds 60 medical school seats in strategic location
- Potential for 60 additional seats with MEC approval
- Expected Net Revenues of R$ 52.4 million at full maturity
- Attractive EV/EBITDA multiple of 3.3x post synergies
- Strategic expansion in Minas Gerais market
- Significant initial cash outlay of R$ 60 million required
- Additional debt burden with R$ 40 million in installments
- Pre-operational status indicates delayed revenue generation
- Contingent payment of up to R$ 60 million for additional seats
Insights
NOVA
The acquisition will add 60 medical school seats to Afya in Contagem, a city in the metropolitan area of
The aggregate purchase price is
Furthermore, there is a potential for 60 additional seats. If approved by the Ministry of Education (“MEC”) within 36 months from the closing date, it will result in an additional payment of
Afya expects an EV/EBITDA of 3.3x at full maturity and post synergies in 2030 with expected Net Revenues of
The transaction's closing is subject to customary and usual conditions, including approval from antitrust regulators.
For more information, please visit https://ir.afya.com.br/news-events/presentations/
About Afya Limited (Nasdaq: AFYA, B3: A2FY34)
Afya is a leading medical education group in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241219793673/en/
Investor Relations Contact:
Afya Limited
ir@afya.com.br
Source: Afya Limited
FAQ
What is the total acquisition cost for AFYA's purchase of Faculdade Única de Contagem?
How many medical seats will AFYA gain from the FUNIC acquisition?
What are the expected financial returns from AFYA's FUNIC acquisition?
How will AFYA pay for the FUNIC acquisition?